Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease Trial Phase 2 Unknown April 16, 2018
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC) Trial Phase 2 Completed April 4, 2018
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients Trial Phase 3 Completed April 3, 2018
Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease Trial N/A Completed April 3, 2018
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Trial Phase 3 Completed April 1, 2018
Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease Trial Phase 2 Terminated March 29, 2018
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia Trial Phase 1 Terminated March 28, 2018
Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions Trial Phase 3 Completed March 26, 2018
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). Trial Phase 4 Terminated March 25, 2018
Speed of Processing Training in Patients With Parkinson's Disease and Healthy Older Adults Trial N/A Completed March 25, 2018
Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED) Trial Phase 2 Withdrawn March 21, 2018